azid
tmsn
sncl
mixtur
transand
anomer
carbon
atom
led
format
equimolar
mixtur
cisand
effici
separ
cycloaddit
pure
transand
select
alkyn
gave
respect
nucleosid
mimet
contain
linker
isoxazolidin
phosphon
obtain
herein
evalu
vitro
activ
varieti
dna
rna
virus
none
compound
endow
antivir
activ
subtox
concentr
compound
cytostat
higher
micromolar
rang
h
nmr
mhz
c
j
hz
poch
ch
j
hz
poch
ch
dddd
j
hz
ddd
j
hz
ch
en
dddd
j
hz
poch
ch
dd
j
hz
c
nmr
mhz
cdcl
intens
search
drug
effect
chemotherapi
viral
infect
andor
variou
cancer
way
decad
idea
structur
modif
nucleosid
nucleotid
gain
interest
fairli
earli
appear
fruit
suppli
wide
varieti
market
compound
ribavirin
zidovudin
adefovir
mani
other
fig
gener
modif
includ
replac
phosphat
p
eoec
bond
nonhydrolys
phosphon
p
ec
linkag
furanos
ring
heterocycl
even
acycl
fragment
natur
nucleobas
unnatur
substitut
heteroaromat
even
homoaromat
system
sever
function
tri
linker
aliphat
chain
well
aliphat
aromat
homoand
heterocycl
system
exemplifi
long
list
exampl
among
commonli
appli
linker
ring
special
interest
sinc
extrem
easili
prepar
cycloaddit
biolog
activ
mani
deriv
recognis
fig
idea
retain
natur
nucleobas
simultan
introduct
functionalis
unit
furanos
ring
led
compound
show
antivir
activ
hand
triazolonucleosid
display
antitumour
activ
recent
kim
et
al
design
novel
nucleosid
anticanc
activ
demonstr
variou
acyclonucleosid
acyclonucleosid
phosphon
contain
unit
obtain
npropargyl
nucleobas
antivir
activ
evalu
among
pyrimidineand
purinecontain
deriv
appear
potent
far
exhibit
antihcv
activ
ic
valu
mm
without
cytotox
concentr
mm
basi
similar
idea
novel
nucleosid
link
dna
nucleobas
recognit
element
synthesis
antivir
activ
evalu
recent
succeed
synthesi
nsubstitut
cphosphoryl
nitron
applic
cycloaddit
vinyl
acet
describ
furthermor
use
precursor
synthesi
isoxazolidin
nucleosid
analogu
recent
demonstr
scheme
continu
effort
novel
class
isoxazolidin
nucleosid
scheme
design
although
glycosyl
well
furanosyl
azid
commonli
use
direct
synthesi
substitut
best
knowledg
isoxazolidin
analogu
remain
unknown
herein
wish
report
effici
synthesi
transform
azid
respect
nucleosid
mimet
aim
studi
prepar
small
librari
nucleotid
analogu
base
idea
replac
furanos
ring
isoxazolidin
system
introduct
linker
isoxazolidin
respect
purin
pyrimidin
nucleobas
aromat
function
nucleobas
replac
scheme
mixtur
transand
obtain
nmethylcphosphoryl
nitron
vinyl
acet
previous
describ
mixtur
immedi
treat
tmsn
presenc
sncl
catalyst
give
ratio
scheme
cleanli
separ
silica
gel
column
less
polar
diastereoisom
polar
sinc
almost
equimolar
mixtur
anomer
azid
detect
crude
product
replac
acetoxi
group
azid
function
occur
via
format
respect
oxonium
intermedi
circumst
nucleophil
attack
face
isoxazolidinium
ion
form
azid
ca
anomer
mixtur
rel
configur
diastereoisomer
isoxazolidin
establish
base
h
c
nmr
spectroscop
data
analysi
vicin
coupl
constant
extract
spectra
isom
j
h
eh
fig
time
ci
relationship
substitu
unambigu
prove
next
cycloaddit
propargyl
nucleobas
select
ethynyl
aryl
examin
scheme
tabl
interest
format
singl
regioisom
substitut
reaction
carri
equimolar
amount
respect
dipolarophil
use
cu
catalyst
accord
procedur
describ
sharpless
inde
cleanli
transform
substitut
good
excel
yield
wherea
respect
alkyn
isoxazolidin
produc
exclus
cycloaddit
epimer
isoxazolidin
ring
observ
addit
evid
support
configur
assign
azidoisoxazolidin
come
comparison
h
c
nmr
spectroscop
data
respect
isoxazolidin
base
vicin
coupl
j
h
eh
hz
j
h
eh
hz
j
h
ep
hz
j
h
ep
hz
j
h
eh
hz
j
h
eh
hz
j
cccp
hz
observ
h
c
nmr
spectra
isoxazolidin
conclud
exist
e
conform
observ
azidoisoxazolidin
fig
hand
prefer
e
conform
isoxazolidin
establish
base
vicin
coupl
constant
deriv
nmr
spectra
j
h
eh
fig
isoxazolidin
evalu
inhibitori
activ
wide
varieti
dna
rna
virus
use
follow
cellbas
assay
human
embryon
lung
hel
cell
herp
simplex
ko
herp
simplex
g
herp
simplex
tk
ko
acv
r
vaccinia
viru
vesicular
stomat
viru
cytomegaloviru
strain
davi
strain
varicellaezost
viru
tk
vzv
strain
oka
tk
vzv
strain
b
vero
e
crfk
cell
cultur
felin
herp
viru
fhv
felin
corona
viru
fipv
f
cem
cell
cultur
human
immunodefici
viru
type
ganciclovir
cidofovir
acyclovir
brivudin
adenin
dhpa
oseltamivir
ribavirin
use
refer
compound
antivir
activ
express
ec
compound
concentr
requir
reduc
viru
plaqu
format
vzv
reduc
virusinduc
cytopathogen
virus
unfortun
inhibitori
activ
viru
detect
evalu
compound
mm
cytotox
test
compound
toward
uninfect
host
cell
defin
minimum
compound
concentr
mcc
caus
microscop
detect
alter
normal
cell
morpholog
cytostat
concentr
cc
caus
decreas
cell
prolifer
determin
murin
leukaemia
human
lymphocyt
cem
human
cervix
carcinoma
hela
human
lung
fibroblast
hel
cell
none
test
compound
affect
cell
morpholog
hel
hela
vero
mdck
crfk
cell
concentr
mm
howev
sever
compound
abl
inhibit
cell
prolifer
cc
concentr
rang
mm
hel
cell
mm
cem
hela
cell
tabl
activ
cell
prolifer
inhibitor
isomer
isoxazolidin
exhibit
sever
common
structur
featur
sixmemb
aromat
ring
benzen
pyridin
substitut
fluorin
aromat
fragment
compound
fulfil
requir
consid
nonpolar
nucleosid
isoster
azid
mixtur
transand
trimethylsilyl
azid
presenc
sncl
gave
easili
separ
mixtur
diethyl
seri
obtain
good
excel
yield
azid
via
cycloaddit
respect
propargyl
nucleobas
ethynyl
aryl
rel
configur
well
cycloadduct
establish
base
conform
analysi
use
vicin
coupl
constant
extract
h
c
nmr
spectra
synthesis
transand
ci
isoxazolidinephosphon
evalu
broadspectrum
virus
found
activ
mm
unsubstitut
fluorosubstitut
phenyl
deriv
prove
slightli
cytostat
middl
higher
micromolar
rang
mm
h
nmr
spectra
taken
cdcl
c
varian
spectromet
tm
intern
standard
c
nmr
spectra
record
cdcl
solut
varian
machin
mhz
p
nmr
spectra
taken
cdcl
c
varian
mhz
ir
spectra
measur
infin
ftir
spectromet
melt
point
determin
boetiu
apparatu
uncorrect
element
analys
perform
tabl
cytostat
activ
compound
cc
mm
inhibitori
concentr
compound
concentr
requir
inhibit
cell
prolifer
microanalyt
laboratori
faculti
perkineelm
pe
chn
analys
follow
adsorb
use
column
chromatographi
merck
silica
gel
mesh
analyt
tlc
merck
tlc
plastic
sheet
silica
gel
f
start
materi
solvent
dri
accord
literatur
method
nitron
isoxazolidin
previous
report
solut
mixtur
g
mmol
dri
methylen
chlorid
ml
trimethylsilyl
azid
ml
mmol
ad
c
argon
follow
sncl
ml
mmol
reaction
mixtur
stir
temperatur
h
satur
aqueou
nahco
ml
ad
c
stir
min
temperatur
organ
phase
separ
aqueou
layer
extract
methylen
chlorid
ml
combin
organ
layer
wash
satur
aqueou
nahco
ml
dri
mgso
filter
solvent
remov
reduc
pressur
purif
silica
gel
column
toluen
isopropanol
vv
gave
azidoisoxazolidin
g
azidoisoxazolidin
g
colourless
oil
solut
azidoisoxazolidin
mmol
tertbutanol
ml
cuso
mmol
water
ml
ad
follow
sodium
ascorb
mmol
respect
alkyn
mmol
reaction
mixtur
stir
room
temperatur
h
concentr
coevapor
ethanol
ml
residu
dissolv
chloroform
ml
dri
mgso
filter
pad
celit
solut
evapor
reduc
pressur
crude
product
purifi
silica
gel
column
chloroform
methanol
vv
eluent
yl
methyl
azidoisoxazolidin
g
mmol
n
g
mmol
phosphon
g
obtain
colourless
oil
purif
silica
gel
chloroformemethanol
vv
ir
film
cm
n
max
azidoisoxazolidin
g
mmol
ml
mmol
phosphon
g
obtain
colourless
oil
purif
silica
gel
chloroformemethanol
vv
ir
film
cm
chloroformemethanol
vv
ir
film
cm
murin
leukaemia
human
tlymphocyt
cem
human
cervix
carcinoma
hela
human
lung
fibroblast
hel
cell
suspend
cellsml
cultur
medium
ml
cell
suspens
ad
ml
appropri
dilut
test
compound
well
microtit
plate
incub
c
two
three
cem
hela
hel
day
cell
number
determin
use
coulter
counter
ic
defin
compound
concentr
requir
inhibit
cell
prolifer
